Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs
暂无分享,去创建一个
Jennifer G. Abelin | N. Hacohen | D. Keskin | C. Rice | J. Sidney | A. Sette | Susan Klaeger | M. Sade-Feldman | K. Clauser | P. Sabeti | S. Sarkizova | S. Weingarten-Gabbay | Steve Carr | A. Nachshon | N. Bhardwaj | K. Manakongtreecheep | M. Gentili | N. Charland | A. Gonye | I. Gushterova | H. Khanna | T. LaSalle | K. Lavin-Parsons | C. Lodenstein | J. Margolin | M. Rojas-Lopez | B. Russo | N. Sharma | J. Tantivit | D. Barouch | Keith D. Rivera | Mohsan Saeed | M. Maus | W. Dunn | C. Tomkins-Tinch | A. Chandrashekar | M. R. Bauer | D. Pregibon | M. Carrington | Matthew R. Bauer | C. C. Bozkus | Yaara Finkel | Hannah B. Taylor | Hasahn L. Conway | Suzanna Rachimi | Vipheaviny Chea | C. Tarr | Brendan N Lilley | Kathleen M. E. Gallagher | Isabel Carulli | K. Katsis | B. Parry | B. Mckaig | Da-Yuan Chen | Leah R. Pearlman | Yuntong Wang | Del Leistritz-Edwards | Melissa Durkin | Kendall Blair Brendan Carl Brenna Nicole Hargun Justin Ann Lavin-Parsons Parry Lilley Lodenstein McK | Molly Fisher Thomas | Nicole C. Charland | Anna L. K. Gonye | Irena Gushterova | Hargun K. Khanna | Thomas J. LaSalle | Kendall M. Lavin-Parsons | Carl L. Lodenstein | Kasidet Manakongtreecheep | Brenna N. Mckaig | Maricarmen Rojas-Lopez | Brian C. Russo | Nihaarika Sharma | Moshe Sade-Feldman | Jessica Tantivit | Siranush Sarkizova
[1] M. Maus,et al. SARS -CoV-2 T-cell immunity to variants of concern following vaccination , 2021, bioRxiv.
[2] Benjamin P. Roscoe,et al. Allelic variation in Class I HLA determines pre-existing memory responses to SARS-CoV-2 that shape the CD8+ T cell repertoire upon viral exposure , 2021, bioRxiv.
[3] M. Nielsen,et al. SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8+ T cell activation in COVID-19 patients , 2021, Science Immunology.
[4] Chase W. Nelson,et al. Conflicting and ambiguous names of overlapping ORFs in the SARS-CoV-2 genome: A homology-based resolution , 2021, Virology.
[5] D. Fremont,et al. Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies , 2021, Nature Medicine.
[6] R. Scheuermann,et al. Negligible impact of SARS-CoV-2 variants on CD4+ and CD8+ T cell reactivity in COVID-19 exposed donors and vaccinees. , 2021, bioRxiv.
[7] N. Sullivan,et al. Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine - Preliminary Report. , 2021, The New England journal of medicine.
[8] Heidi Ledford. How ‘killer’ T cells could boost COVID immunity in face of new variants , 2021, Nature.
[9] O. Laeyendecker,et al. CD8+ T cell responses in COVID-19 convalescent individuals target conserved epitopes from multiple prominent SARS-CoV-2 circulating variants , 2021, medRxiv.
[10] S. Mallal,et al. Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases , 2021, Cell Reports Medicine.
[11] A. Casadevall,et al. SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individuals. , 2021, The Journal of clinical investigation.
[12] E. Lander,et al. The SARS-CoV-2 RNA–protein interactome in infected human cells , 2020, Nature Microbiology.
[13] S. Mallal,et al. Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases , 2020, bioRxiv.
[14] M. Matsui,et al. Identification of HLA-A*02:01-Restricted Candidate Epitopes Derived from the Nonstructural Polyprotein 1a of SARS-CoV-2 That May Be Natural Targets of CD8+ T Cell Recognition In Vivo , 2020, Journal of Virology.
[15] I. Ulitsky,et al. SARS-CoV-2 utilizes a multipronged strategy to suppress host protein synthesis , 2020, bioRxiv.
[16] Bjoern Peters,et al. Immunological memory to SARS-CoV-2 assessed for up to eight months after infection , 2020, bioRxiv.
[17] Mark M. Davis,et al. Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19 , 2020, Cell.
[18] Jourdan K. Ewoldt,et al. SARS-CoV-2 desensitizes host cells to interferon through inhibition of the JAK-STAT pathway , 2020, bioRxiv.
[19] G. MacBeath,et al. Unbiased Screens Show CD8+ T Cells of COVID-19 Patients Recognize Shared Epitopes in SARS-CoV-2 that Largely Reside outside the Spike Protein , 2020, Immunity.
[20] M. Nielsen,et al. SARS-CoV-2 genome-wide mapping of CD8 T cell recognition reveals strong immunodominance and substantial CD8 T cell activation in COVID-19 patients , 2020, bioRxiv.
[21] J. Greenbaum,et al. Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity , 2020, Cell.
[22] Maria Virginia Ruiz Cuevas,et al. Most non-canonical proteins uniquely populate the proteome or immunopeptidome. , 2020, Cell reports.
[23] H. Achdout,et al. The coding capacity of SARS-CoV-2 , 2020, Nature.
[24] P. Doherty,et al. Suboptimal SARS-CoV-2−specific CD8+ T cell response associated with the prominent HLA-A*02:01 phenotype , 2020, Proceedings of the National Academy of Sciences.
[25] N. Krogan,et al. SARS-CoV-2 ORF9c Is a Membrane-Associated Protein that Suppresses Antiviral Responses in Cells , 2020, bioRxiv.
[26] M. V. van Buuren,et al. Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopes , 2020, Genome Medicine.
[27] E. Walsh,et al. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults , 2020, Nature.
[28] D. Altmann,et al. SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection , 2020, Science Immunology.
[29] Martin Linster,et al. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls , 2020, Nature.
[30] Edward C. Holmes,et al. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology , 2020, Nature Microbiology.
[31] J. Mascola,et al. An mRNA Vaccine against SARS-CoV-2 — Preliminary Report , 2020, The New England journal of medicine.
[32] N. Ban,et al. SARS-CoV-2 Nsp1 binds ribosomal mRNA channel to inhibit translation , 2020, bioRxiv.
[33] Morten Nielsen,et al. Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19 , 2020, Cell.
[34] A. Sette,et al. Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome , 2020, Science Immunology.
[35] James T. Gordy,et al. The Nucleocapsid Protein of SARS–CoV-2: a Target for Vaccine Development , 2020, Journal of Virology.
[36] M. Park,et al. Immune evasion via SARS-CoV-2 ORF8 protein? , 2020, Nature Reviews Immunology.
[37] G. A. Efimov,et al. SARS-CoV-2 Epitopes Are Recognized by a Public and Diverse Repertoire of Human T Cell Receptors , 2020, Immunity.
[38] T. Pan,et al. The ORF8 Protein of SARS-CoV-2 Mediates Immune Evasion through Potently Downregulating MHC-I , 2020, bioRxiv.
[39] J. Greenbaum,et al. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals , 2020, Cell.
[40] M. Schwartz,et al. The coding capacity of SARS-CoV-2 , 2020, Nature.
[41] Benjamin J. Polacco,et al. A SARS-CoV-2 Protein Interaction Map Reveals Targets for Drug-Repurposing , 2020, Nature.
[42] Abhinav Nellore,et al. Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2 , 2020, Journal of Virology.
[43] Katie M. Campbell,et al. Prioritization of SARS-CoV-2 epitopes using a pan-HLA and global population inference approach , 2020, bioRxiv.
[44] E. Callaway. The race for coronavirus vaccines: a graphical guide , 2020, Nature.
[45] Hyeshik Chang,et al. The Architecture of SARS-CoV-2 Transcriptome , 2020, Cell.
[46] R. Scheuermann,et al. A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2 , 2020, Cell Host & Microbe.
[47] M. Mann,et al. Pervasive functional translation of noncanonical human open reading frames , 2020, Science.
[48] N. Hacohen,et al. Thousands of novel unannotated proteins expand the MHC I immunopeptidome in cancer , 2020, bioRxiv.
[49] E. Holmes,et al. A new coronavirus associated with human respiratory disease in China , 2020, Nature.
[50] E. Holmes,et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding , 2020, The Lancet.
[51] N. Hacohen,et al. A large peptidome dataset improves HLA class I epitope prediction across most of the human population , 2019, Nature Biotechnology.
[52] M. Schwartz,et al. Comprehensive annotations of human herpesvirus 6A and 6B genomes reveal novel and conserved genomic features , 2019, bioRxiv.
[53] D. Tscharke,et al. Quantification of epitope abundance reveals the effect of direct and cross-presentation on influenza CTL responses , 2019, Nature Communications.
[54] Bonnie Berger,et al. Efficient integration of heterogeneous single-cell transcriptomes using Scanorama , 2019, Nature Biotechnology.
[55] A. Heck,et al. Pre-fractionation Extends but also Creates a Bias in the Detectable HLA Class Ι Ligandome , 2019, Journal of proteome research.
[56] A. Butte,et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage , 2018, Nature Immunology.
[57] M. Altfeld,et al. Interactions Between KIR3DS1 and HLA-F Activate Natural Killer Cells to Control HCV Replication in Cell Culture. , 2018, Gastroenterology.
[58] Kevin R. Moon,et al. Recovering Gene Interactions from Single-Cell Data Using Data Diffusion , 2018, Cell.
[59] Ralf Zimmer,et al. Improved Ribo-seq enables identification of cryptic translation events , 2018, Nature Methods.
[60] Javier G. Magadán,et al. Influenza A Virus Negative Strand RNA Is Translated for CD8+ T Cell Immunosurveillance , 2018, The Journal of Immunology.
[61] Fabian J Theis,et al. SCANPY: large-scale single-cell gene expression data analysis , 2018, Genome Biology.
[62] Markus Müller,et al. High-throughput and Sensitive Immunopeptidomics Platform Reveals Profound Interferonγ-Mediated Remodeling of the Human Leukocyte Antigen (HLA) Ligandome* , 2017, Molecular & Cellular Proteomics.
[63] Jennifer G. Abelin,et al. Mass Spectrometry Profiling of HLA‐Associated Peptidomes in Mono‐allelic Cells Enables More Accurate Epitope Prediction , 2017, Immunity.
[64] David Gfeller,et al. Unsupervised HLA Peptidome Deconvolution Improves Ligand Prediction Accuracy and Predicts Cooperative Effects in Peptide–HLA Interactions , 2016, The Journal of Immunology.
[65] B. Walker,et al. Analysis of Major Histocompatibility Complex-Bound HIV Peptides Identified from Various Cell Types Reveals Common Nested Peptides and Novel T Cell Responses , 2016, Journal of Virology.
[66] N. Shastri,et al. Nowhere to hide: unconventional translation yields cryptic peptides for immune surveillance , 2016, Immunological reviews.
[67] Marco Y. Hein,et al. The Perseus computational platform for comprehensive analysis of (prote)omics data , 2016, Nature Methods.
[68] Arun K. Ghosh,et al. Defining Viral Defective Ribosomal Products: Standard and Alternative Translation Initiation Events Generate a Common Peptide from Influenza A Virus M2 and M1 mRNAs , 2016, The Journal of Immunology.
[69] M. Nielsen,et al. Defining the HLA class I‐associated viral antigen repertoire from HIV‐1‐infected human cells , 2015, European journal of immunology.
[70] I. Hoof,et al. Measles Virus Epitope Presentation by HLA: Novel Insights into Epitope Selection, Dominance, and Microvariation , 2015, Front. Immunol..
[71] Guang Lan Zhang,et al. Physical detection of influenza A epitopes identifies a stealth subset on human lung epithelium evading natural CD8 immunity , 2015, Proceedings of the National Academy of Sciences.
[72] Nicholas T Ingolia,et al. Ribosome profiling reveals pervasive translation outside of annotated protein-coding genes. , 2014, Cell reports.
[73] Clemencia Pinilla,et al. Measurement of MHC/Peptide Interactions by Gel Filtration or Monoclonal Antibody Capture , 2013, Current protocols in immunology.
[74] Anthony W. Purcell,et al. Kinetics of Antigen Expression and Epitope Presentation during Virus Infection , 2013, PLoS pathogens.
[75] Marco Y. Hein,et al. Decoding Human Cytomegalovirus , 2012, Science.
[76] R. Ketteler. On programmed ribosomal frameshifting: the alternative proteomes , 2012, Front. Gene..
[77] J. Neefjes,et al. Towards a systems understanding of MHC class I and MHC class II antigen presentation , 2011, Nature Reviews Immunology.
[78] Nicholas T. Ingolia,et al. Ribosome Profiling of Mouse Embryonic Stem Cells Reveals the Complexity and Dynamics of Mammalian Proteomes , 2011, Cell.
[79] M. Selbach,et al. Global quantification of mammalian gene expression control , 2011, Nature.
[80] D. Watkins,et al. CD8+ T Cell Recognition of Cryptic Epitopes Is a Ubiquitous Feature of AIDS Virus Infection , 2010, Journal of Virology.
[81] M. Bouvier,et al. MHC class I antigen presentation: learning from viral evasion strategies , 2009, Nature Reviews Immunology.
[82] Nicholas T. Ingolia,et al. Genome-Wide Analysis in Vivo of Translation with Nucleotide Resolution Using Ribosome Profiling , 2009, Science.
[83] Cole Trapnell,et al. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome , 2009, Genome Biology.
[84] A. Hinnebusch,et al. Regulation of Translation Initiation in Eukaryotes: Mechanisms and Biological Targets , 2009, Cell.
[85] Steven J Mack,et al. Balancing selection and heterogeneity across the classical human leukocyte antigen loci: a meta-analytic review of 497 population studies. , 2008, Human immunology.
[86] M. Loeb,et al. Epitope discovery in West Nile virus infection: Identification and immune recognition of viral epitopes , 2008, Proceedings of the National Academy of Sciences.
[87] R. Zinkernagel,et al. Immunological Memory , 2006 .
[88] K. Tao,et al. Induction of SARS-nucleoprotein-specific immune response by use of DNA vaccine , 2004, Immunology Letters.
[89] J. Altman,et al. MHC‐Peptide Tetramers to Visualize Antigen‐Specific T Cells , 2003, Current protocols in immunology.
[90] Andrew H. Thompson,et al. Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS. , 2003, Analytical chemistry.
[91] D. Kostyu,et al. Ramifications of HLA class I polymorphism and population genetics for vaccine development , 2001, Genetic epidemiology.
[92] A Sette,et al. Two complementary methods for predicting peptides binding major histocompatibility complex molecules. , 1997, Journal of molecular biology.
[93] Y. Cheng,et al. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.